BTC
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Iparomlimab and Tuvonralimab Injection Combined With GemOX and Lenvatinib as Conversion Therapy for Initially Potentially Resectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer (NCT07263360) | Tianjin Medical University Cancer Institute and Hospital | 2026-02-01 |
| Surgical Total Clearance Versus Extrahepatic Bile Duct Preservation for Biliary Tract Malignancies: A Single-Center, Randomized, Two-Arm, Prospective Phase II Clinical Trial (NCT07609641) | Tianjin Medical University Cancer Institute and Hospital | 2025-10-20 |
Track BTC automatically
Every clearance here is in the API, with alerts when new ones post.